NCT00936754

Safety and Efficacy of a Single Dose of a Polyphenol-enriched Brown Seaweed Powder in Human

Safety and Efficacy of a Unique Dose of a Brown Seaweeds Powder Enriched in Polyphenols on Human

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 23 (estimated)
• Sponsor: innoVactiv Inc. · Industry
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Accepted

Summary

The primary endpoint of this trial will be to evaluate the safety of a single administration in human of a dose of 500 mg of a polyphenol-rich algal powder when taken 30 minutes before a test meal. The secondary endpoint of this trial will be to evaluate if a single administration in human of a dose of 500 mg of a polyphenol-rich algal powder is able to reduce the rate of carbohydrate absorption as measured by following postprandial glycemia and insulinemia.

Conditions

• Glycemic Index

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Brown seaweed powder	500 mg (in two 250 mg capsules) taken with 250 ml of water 30 minutes before test meal (110g of plain white bread with 250 ml of water)
DIETARY_SUPPLEMENT	Placebo	Two capsules similar in aspect and weight to active product, taken with 250 ml of water 30 minutes before test meal (110g of plain white bread with 250 ml of water)

Timeline

• Start date: 2009-07-01
• Primary completion: 2009-11-01
• Completion: 2010-01-01
• First posted: 2009-07-10
• Last updated: 2010-01-20

Locations

1 site across 1 country: Canada